Aurora Cannabis Q1 Preview: What to expect
Aurora Cannabis ( ACB) is due to report first-quarter earnings on August 5, with analysts’ consensus pointing towards another loss-making quarter. The marijuana producer is projected to report a loss …
Why Is Canopy Growth (NASDAQ:CGC) Leading Cannabis Stock Discussion?
Canopy Growth (CGC) leads a fresh US cannabis stocks review as earnings, peers and macro signals reshape the market debate.
One of the best cannabis stocks to buy
Recently, there was also a hearing to consider moving even more cannabis products into Schedule III. These changes may have a wide-ranging impact on the industry, and one company that could benefit …
Cannabis MSO Vireo Growth to acquire Planet 13 in all-stock deal
Vireo adds 36 dispensaries across three states to its portfolio, including Planet 13’s flagship Las Vegas store and a consumption lounge.
SNDL Q2 Earnings Call Highlights
SNDL (NASDAQ:SNDL) reported lower second-quarter revenue and gross profit as demand weakness across liquor and cannabis markets, cannabis-production ramp-up costs and promotional activity weighed on …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
One of the best cannabis stocks to buy
Recently, there was also a hearing to consider moving even more cannabis products into Schedule III. These changes may have a wide-ranging impact on the industry, and one company that could benefit …
Cannabis MSO Vireo Growth to acquire Planet 13 in all-stock deal
Vireo adds 36 dispensaries across three states to its portfolio, including Planet 13’s flagship Las Vegas store and a consumption lounge.
SNDL Q2 Earnings Call Highlights
SNDL (NASDAQ:SNDL) reported lower second-quarter revenue and gross profit as demand weakness across liquor and cannabis markets, cannabis-production ramp-up costs and promotional activity weighed on …
Cannabis Was Ready For Wall St., But Was Wall St. Ready For Cannabis?
Trulieve and Glass House’s NYSE uplistings mark a milestone, but experts warn of investor education gaps, geographic complexity, and a five-year capital drought.
ACB stock down 28% in three months: Time to buy the dip or cash out?
Shares of Aurora Cannabis ACB have lost 27% over the past three months, despite the cannabis operator delivering better-than-expected fourth-quarter 2026 (year ended March 2026) revenues and earnings.
Why Is Aurora Cannabis (NASDAQ:ACB) Back In Focus?
Aurora Cannabis gains attention after fresh recognition highlights its medical cannabis operations, product quality, compliance, and global reach.
MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks
The AdvisorShares Pure US Cannabis ETF is rated a buy, driven by real regulatory progress and potential further catalysts. Click here to read more on MSOS.
Why Is Trulieve Cannabis (NYSE:TRLV) Watching NYSE Composite?
Explore Trulieve Cannabis (NYSE:TRLV), operating across regulated cannabis markets, with insights into business operations, Florida presence, and the company’s role within the NYSE Composite.
Is Canopy Growth stock finally worth buying after losing 99% of its value?
A lower stock price doesn’t eliminate investment risk.
Recent Comments